All Stories

  1. How to Manage Acquired Bleeding Disorders
  2. Gene transfer in hemophilia B: a big step forward
  3. Hemophilia B: Diagnosis and Management
  4. Hemostatic Abnormalities in Gaucher Disease: Mechanisms and Clinical Implications
  5. Current and emerging biologics for the treatment of hemophilia
  6. Advances in diagnosis of von Willebrand disease
  7. An international collaborative study to compare different von Willebrand factor glycoprotein Ib binding activity assays: the COMPASS-VWF study
  8. The benefits of prophylaxis in patients with hemophilia B
  9. Management of thrombocytopenia in cancer
  10. Comorbidities in persons with haemophilia aged 60 years or more compared with age-matched people from the general population
  11. Haematological Care of the Haemophilic Patient
  12. Laboratory Aspects
  13. Pathogenesis of the Haemophilic Arthropathy
  14. Pharmacokinetic Approach to the Treatment of Haemophilia
  15. Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series
  16. Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
  17. Emerging Issues in Diagnosis, Biology, and Inhibitor Risk in Mild Hemophilia A
  18. Type 2B von Willebrand Disease
  19. How I treat type 2 variant forms of von Willebrand disease
  20. 2B or not 2B: when VWF is not a good platelet friend
  21. New development in von Willebrand disease
  22. How I treat von Willebrand disease
  23. Desmopressin for the treatment of haemophilia
  24. Treatment of von Willebrand disease
  25. Current Management of von Willebrand??s Disease
  26. Acquired transitory von Willebrand syndrome with ciprofloxacin